MUMBAI, India, Jan. 2 -- Intellectual Property India has published a patent application (202541123915 A) filed by V. Pallavi; STV Raghavamma; M. Jhansi Laxmi; and Tella Jaidivya, Guntur, Andhra Pradesh, on Dec. 9, 2025, for 'biointelligent hydrogels and precision nanocarrier vaginal platforms: accelerating next-generation, user-centric technologies for women's reproductive health.'
Inventor(s) include V. Pallavi; STV Raghavamma; M. Jhansi Laxmi; and Tella Jaidivya.
The application for the patent was published on Jan. 2, under issue no. 01/2026.
According to the abstract released by the Intellectual Property India: "The proposed platform is based on the synergistic integration of biointelligent, stimuli-responsive hydrogels with precision-engineered nanocarriers, designed to achieve localized, prolonged, and physiologically tunable drug delivery within the vaginal microenvironment. The hydrogel matrix is engineered to exploit polymer-mucin interfacial dynamics, ionic crosslinking, and pH-sensitive structural rearrangements to enable enhanced tissue adhesion, hydration-controlled swelling, and controlled diffusional pathways. Embedded lipid/polymer nanocarriers introduce a secondary level of release control via nano-enabled permeability modulation, drug-excipient molecular interactions, and surface-charge-regulated mucosal penetration. Together, the multi-tier system provides spatiotemporal drug release, mucosal retention, epithelial compatibility, and microbiome-friendly performance, rooted in principles of mucosal biophysics, polymer network engineering, supramolecular assembly, and nanoscale transport phenomena."
Disclaimer: Curated by HT Syndication.
